Clayton Dehn, MS

Chief Scientific Officer

  • Published in numerous peer-reviewed journal articles
  • Conducted 160+ Phase I-IV clinical trials with challenging population inclusive of Diabetes, Vulvovaginal Candidiasis, Healthy Volunteers, Hypogonadal, Liver Disease, Coronary Artery Disease, NASH, Postpartum Depression, Alzheimer’s, and many other medical as well as psychiatric indications
  • Commissioner of the Arizona Biomedical Research Commission, Editor-In-Chief of Series of Endocrinology Diabetes and Metabolism and Editorial Board Member of various well-established journals